QQQ   419.63 (-0.89%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.75 (-0.19%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.99 (-1.28%)
CGC   7.72 (-1.40%)
DIS   111.81 (-0.55%)
AMC   3.12 (+6.85%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.18 (+1.40%)
QQQ   419.63 (-0.89%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.75 (-0.19%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.99 (-1.28%)
CGC   7.72 (-1.40%)
DIS   111.81 (-0.55%)
AMC   3.12 (+6.85%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.18 (+1.40%)
QQQ   419.63 (-0.89%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.75 (-0.19%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.99 (-1.28%)
CGC   7.72 (-1.40%)
DIS   111.81 (-0.55%)
AMC   3.12 (+6.85%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.18 (+1.40%)
QQQ   419.63 (-0.89%)
AAPL   165.60 (-0.86%)
MSFT   402.53 (-0.43%)
META   489.57 (-2.44%)
GOOGL   155.31 (-0.45%)
AMZN   176.52 (-1.51%)
TSLA   149.91 (-0.01%)
NVDA   825.35 (-2.52%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.75 (-0.19%)
T   16.31 (-0.12%)
F   12.13 (+0.58%)
MU   108.96 (-2.65%)
GE   150.99 (-1.28%)
CGC   7.72 (-1.40%)
DIS   111.81 (-0.55%)
AMC   3.12 (+6.85%)
PFE   25.64 (+0.98%)
PYPL   62.01 (-0.14%)
XOM   120.18 (+1.40%)
Free Trial

Bolt Biotherapeutics (BOLT) Insider Trading & Ownership

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)
Free BOLT Stock Alerts
$1.15
+0.01 (+0.88%)
(As of 10:56 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestSocial Media

Bolt Biotherapeutics (NASDAQ:BOLT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
28.40%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$11,233.22
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$125,191.15
Get BOLT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bolt Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BOLT Insider Buying and Selling by Quarter

Ad InvestorPlace
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
Just click here to sign up and be among the first to get it.

Bolt Biotherapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/12/2023William P QuinnCFOBuy7,500$0.95$7,125.00  
12/6/2023William P QuinnCFOBuy2,500$0.78$1,950.00  
11/29/2023Edgar EnglemanDirectorSell25,805$0.91$23,482.55  
11/20/2023Edgar EnglemanDirectorSell31,257$0.92$28,756.44  
11/20/2023Vivo Capital Viii, LlcMajor ShareholderSell54,700$0.92$50,324.00  
11/16/2023Edgar EnglemanDirectorSell8,571$0.96$8,228.16  
11/16/2023Vivo Capital Viii, LlcMajor ShareholderSell15,000$0.96$14,400.00  
6/6/2023William P QuinnCFOBuy1,829$1.18$2,158.22  
(Data available from 1/1/2013 forward)

BOLT Insider Trading Activity - Frequently Asked Questions

Who is on Bolt Biotherapeutics's Insider Roster?

The list of insiders at Bolt Biotherapeutics includes Edgar Engleman, Holdings A/S Novo, Vivo Capital Viii, Llc, and William P Quinn. Learn more on insiders at BOLT.

What percentage of Bolt Biotherapeutics stock is owned by insiders?

28.40% of Bolt Biotherapeutics stock is owned by insiders. Learn more on BOLT's insider holdings.

Which Bolt Biotherapeutics insiders have been buying company stock?

The following insider purchased BOLT shares in the last 24 months: William P Quinn ($11,233.22).

How much insider buying is happening at Bolt Biotherapeutics?

Insiders have purchased a total of 11,829 BOLT shares in the last 24 months for a total of $11,233.22 bought.

Which Bolt Biotherapeutics insiders have been selling company stock?

The following insiders have sold BOLT shares in the last 24 months: Edgar Engleman ($60,467.15), Holdings A/S Novo ($1,600,000.00), and Vivo Capital Viii, Llc ($64,724.00).

How much insider selling is happening at Bolt Biotherapeutics?

Insiders have sold a total of 935,333 Bolt Biotherapeutics shares in the last 24 months for a total of $1,725,191.15 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:BOLT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Urgent alert: open this for a huge profit potential
Timothy Sykes